ERD

3TR | Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

01-09-2019

-

31-08-2026

Show more information

Organisation JANSSEN PHARMACEUTICA NV

c4c | conect4children (COllaborative Network for European Clinical Trials For Children)

01-05-2018

-

30-04-2025

Show more information

Organisation JANSSEN PHARMACEUTICA NV

ConcePTION | Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation

01-04-2019

-

31-12-2024

Show more information

Organisation JANSSEN PHARMACEUTICA NV

ZIKAlliance | A global alliance for Zika virus control and prevention

01-10-2016

-

30-09-2021

Show more information

Organisation JANSSEN PHARMACEUTICA NV

AIMS-2-TRIALS | Autism Innovative Medicine Studies – 2 – Trials

01-06-2018

-

31-05-2025

Show more information

Organisation JANSSEN PHARMACEUTICA NV

HARMONY | Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026

01-01-2017

-

30-06-2023

Show more information

Organisation JANSSEN PHARMACEUTICA NV

IDEA-FAST | Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

01-11-2019

-

30-04-2026

Show more information

Organisation JANSSEN PHARMACEUTICA NV

BIGPICTURE | Central Repository for Digital Pathology

01-02-2021

-

31-01-2027

Show more information

Organisation JANSSEN PHARMACEUTICA NV

HARMONY PLUS | HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS

01-10-2020

-

31-03-2024

Show more information

Organisation JANSSEN PHARMACEUTICA NV

SYNTHIA | Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applications

01-09-2024

-

31-08-2029

Show more information

Organisation JANSSEN PHARMACEUTICA NV

CARE | Corona Accelerated R&D in Europe

01-04-2020

-

31-03-2025

Show more information

Organisation JANSSEN PHARMACEUTICA NV

EU-PEARL | EU Patient- cEntric clinicAl tRial pLatform

01-11-2019

-

30-04-2023

Show more information

Organisation JANSSEN PHARMACEUTICA NV

Gravitate-Health | Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment

01-11-2020

-

31-10-2025

Show more information

Organisation JANSSEN PHARMACEUTICA NV

IDERHA | Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance

01-04-2023

-

31-03-2028

Show more information

Organisation JANSSEN PHARMACEUTICA NV

UNITE4TB | ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS

01-06-2021

-

31-05-2028

Show more information

Organisation JANSSEN PHARMACEUTICA NV

T2EVOLVE | Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy

01-01-2021

-

31-12-2025

Show more information

Organisation JANSSEN PHARMACEUTICA NV

DO-IT | Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055

01-02-2017

-

31-01-2019

Show more information

Organisation JANSSEN PHARMACEUTICA NV

PIONEER | Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope

01-05-2018

-

31-10-2023

Show more information

Organisation JANSSEN PHARMACEUTICA NV

ERA4TB | EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS

01-01-2020

-

31-12-2025

Show more information

Organisation JANSSEN PHARMACEUTICA NV

PARADIGM | Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

01-03-2018

-

30-11-2020

Show more information

Organisation JANSSEN PHARMACEUTICA NV

ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064

01-01-2017

-

31-12-2023

Show more information

Organisation JANSSEN PHARMACEUTICA NV

BEAMER | BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe

01-09-2021

-

31-08-2026

Show more information

Organisation JANSSEN PHARMACEUTICA NV

VICT3R | Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research

01-09-2024

-

29-02-2028

Show more information

Organisation JANSSEN PHARMACEUTICA NV

IMMUcan | Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts

01-03-2019

-

31-08-2025

Show more information

Organisation JANSSEN PHARMACEUTICA NV

ARDAT | Accelerating Research & Development for Advanced Therapies

01-11-2020

-

31-10-2025

Show more information

Organisation JANSSEN PHARMACEUTICA NV

PREFER | Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966

01-10-2016

-

31-05-2022

Show more information

Organisation JANSSEN PHARMACEUTICA NV

RHAPSODY | Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881

01-04-2016

-

30-09-2021

Show more information

Organisation JANSSEN PHARMACEUTICA NV

PharmaLedger | PharmaLedger

01-01-2020

-

31-12-2022

Show more information

Organisation JANSSEN PHARMACEUTICA NV

ADAPT-SMART | Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890

01-07-2015

-

30-04-2018

Show more information

Organisation JANSSEN PHARMACEUTICA NV

Trials@Home | Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials

01-09-2019

-

30-11-2025

Show more information

Organisation JANSSEN PHARMACEUTICA NV

Projects overview

Selected filters:

3TR | Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

c4c | conect4children (COllaborative Network for European Clinical Trials For Children)

ConcePTION | Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation

ZIKAlliance | A global alliance for Zika virus control and prevention

AIMS-2-TRIALS | Autism Innovative Medicine Studies – 2 – Trials

HARMONY | Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026

IDEA-FAST | Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

BIGPICTURE | Central Repository for Digital Pathology

HARMONY PLUS | HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS

SYNTHIA | Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applications

CARE | Corona Accelerated R&D in Europe

EU-PEARL | EU Patient- cEntric clinicAl tRial pLatform

Gravitate-Health | Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment

IDERHA | Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance

UNITE4TB | ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS

T2EVOLVE | Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy

DO-IT | Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055

PIONEER | Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope

ERA4TB | EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS

PARADIGM | Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064

BEAMER | BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe

VICT3R | Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research

IMMUcan | Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts

ARDAT | Accelerating Research & Development for Advanced Therapies

PREFER | Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966

RHAPSODY | Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881

PharmaLedger | PharmaLedger

ADAPT-SMART | Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890

Trials@Home | Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials